85 related articles for article (PubMed ID: 9168059)
1. JAK3: expression and mapping to chromosome 19p12-13.1.
Safford MG; Levenstein M; Tsifrina E; Amin S; Hawkins AL; Griffin CA; Civin CI; Small D
Exp Hematol; 1997 May; 25(5):374-86. PubMed ID: 9168059
[TBL] [Abstract][Full Text] [Related]
2. Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells.
Hoehn GT; Stokland T; Amin S; RamÃrez M; Hawkins AL; Griffin CA; Small D; Civin CI
Oncogene; 1996 Feb; 12(4):903-13. PubMed ID: 8632913
[TBL] [Abstract][Full Text] [Related]
3. Structural organization and chromosomal mapping of JAK3 locus.
Kumar A; Toscani A; Rane S; Reddy EP
Oncogene; 1996 Nov; 13(9):2009-14. PubMed ID: 8934548
[TBL] [Abstract][Full Text] [Related]
4. Genomic sequence, organization, and chromosomal localization of human JAK3.
Riedy MC; Dutra AS; Blake TB; Modi W; Lal BK; Davis J; Bosse A; O'Shea JJ; Johnston JA
Genomics; 1996 Oct; 37(1):57-61. PubMed ID: 8921370
[TBL] [Abstract][Full Text] [Related]
5. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
6. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane SG; Reddy EP
Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
[TBL] [Abstract][Full Text] [Related]
7. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
[TBL] [Abstract][Full Text] [Related]
8. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
9. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
[TBL] [Abstract][Full Text] [Related]
10. JAK3 maps to human chromosome 19p12 within a cluster of proto-oncogenes and transcription factors.
Hoffman SM; Lai KS; Tomfohrde J; Bowcock A; Gordon LA; Mohrenweiser HW
Genomics; 1997 Jul; 43(1):109-11. PubMed ID: 9226382
[No Abstract] [Full Text] [Related]
11. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.
Takahashi T; Shirasawa T
FEBS Lett; 1994 Apr; 342(2):124-8. PubMed ID: 8143863
[TBL] [Abstract][Full Text] [Related]
12. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
[TBL] [Abstract][Full Text] [Related]
13. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
14. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
Gurniak CB; Thomis DC; Berg LJ
DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
[TBL] [Abstract][Full Text] [Related]
15. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
[TBL] [Abstract][Full Text] [Related]
16. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
17. Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia.
Wood CM; Goodman PA; Uckun FM
Leuk Lymphoma; 2002 Dec; 43(12):2355-62. PubMed ID: 12613524
[TBL] [Abstract][Full Text] [Related]
18. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
19. The receptor tyrosine kinase-related gene (ryk) demonstrates lineage and stage-specific expression in hematopoietic cells.
Simoneaux DK; Fletcher FA; Jurecic R; Shilling HG; Van NT; Patel P; Belmont JW
J Immunol; 1995 Feb; 154(3):1157-66. PubMed ID: 7822791
[TBL] [Abstract][Full Text] [Related]
20. Jak3 negatively regulates dendritic-cell cytokine production and survival.
Yamaoka K; Min B; Zhou YJ; Paul WE; O'shea JJ
Blood; 2005 Nov; 106(9):3227-33. PubMed ID: 16020505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
